IL10 and acute lymphoblastic leukemia: Cell cycle arrest is one of the most accepted mechanisms explaining MSC antineoplastic activity: an experiment conducted using murine B-cell lymphoma, acute lymphoblastic leukemia (ALL) and erythroleukemia cells reported reduced cell cycle proliferation and IL-10 levels in the presence of murine BM-MSCs [115].